Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MALTA, N.Y., March 09, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (Nasdaq: GFS) (GF) today announced the availability of Auto Grade 1 ready embedded magnetic RAM (eMRAM) technology on the company’s...
-
SHENZHEN, China, March 09, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, today...
-
--- Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration Key Highlights: Monotherapy and Clinical Outcomes The...
-
EventHorizonIQ, available now at https://eventhorizoniq.com/pricing, provides investors and risk professionals with institutional-grade cross-asset regime intelligence Subscription launch represents...
-
-- The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients...
-
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United...
-
Align agile delivery with enterprise strategy and prove the ROI of your efforts.
-
ROCHESTER, NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for defense tech and other vibrant end-markets, today...
-
Secures critical nuclear-grade graphite required for SOLO™ First-of-a-Kind (FOAK) reactor deployment targeted for 2027 and NOAK commercialization in 2028Initiates procurement following completion of...
-
-- Company will trade on Nasdaq under trading symbol "DMRA" effective March 10, 2026 -- -- On track to submit IND or CTA for DMR-001 in mutant-calreticulin essential thrombocythemia and myelofibrosis...